Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy vs. Endocrine Therapy Alone for Hormone receptor-positive, HER2-negative metastatic breast cancer

Por Lin, Mingxi, Chen, Yang, Jin, Yizi, Hu, Xichun, Zhang, Jian
Publicado no J Cancer (2020)

Development and validation of a nomogram for predicting overall survival of patients with cancer of unknown primary: a real-world data analysis

Por Jin, Yizi, Lin, Mingxi, Luo, Zhiguo, Hu, Xichun, Zhang, Jian
Publicado no Ann Transl Med (2021)

Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer

Por Lin, Mingxi, Jin, Yizi, Yang, Ziyi, Hu, Xichun, Zhang, Jian
Publicado no Ther Adv Med Oncol (2021)

A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple‐negative breast cancer

Por Lin, Mingxi, Jin, Yizi, Jin, Jia, Wang, Biyun, Hu, Xichun, Zhang, Jian
Publicado no Cancer Med (2020)

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

Por Lin, Ying, Lin, Mingxi, Zhang, Jian, Wang, Biyun, Tao, Zhonghua, Du, Yiqun, Zhang, Sheng, Cao, Jun, Wang, Leiping, Hu, Xichun
Publicado no Cancer Res Treat (2020)